Abstract
The sequencing of the human genome and that of numerous pathogens has opened the door for proteomics by providing a sequence-based framework for mining proteomes. As a result, there is intense interest in applying proteomics to foster a better understanding of disease processes, develop new biomarkers for diagnosis and early detection of disease, and accelerate drug development. This interest creates numerous opportunities as well as challenges to meet the needs for high sensitivity and high throughput required for disease-related investigations.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Petricoin, E. F., Zoon, K. C., Kohn, E. C., Barrett, J. C. & Liotta, L. A. Clinical proteomics: translating benchside promise into bedside reality. Nature Rev. Drug Discov. 1, 683–695 (2002).
Hanash, S. 2-D or not 2-D—is there a future for 2-D gels in proteomics? Insights from York proteomic meeting. Proteomics 1, 635–637 (2001).
Hanash, S. M., Madoz-Gurpide, J. & Misek, D. E. Identification of novel targets for cancer therapy using expression proteomics. Leukemia 16, 478–485 (2002).
Van Eyk, J. E. Proteomics: unraveling the complexity of heart disease and striving to change cardiology. Curr. Opin. Mol. Therapeut. 3, 546–553 (2001).
Li, X. P. et al. A two-dimensional gel electrophoresis database of rat heart protein. Electrophoresis 20, 891–897 (1999).
Evans, G., Wheeler, C. H., Corbett, J. M. & Dunn, M. J. Construction of HSC-2D PAGE: a two-dimensional gel electrophoresis database of heart proteins. Electrophoresis 18, 471–479 (1997).
van Der Velden, J. et al. Effects of calcium, inorganic, phosphate, and pH on isometric force in single skinned cardiomyocytes from donor and failing human hearts. Circulation 104, 1140–1146 (2001).
Arrell, D. K., Neverova, I., Fraser, H., Marbán, E. & Van Eyk, J. E. Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1. Circ. Res. 89, 480–487 (2001).
Ping, P., Zhang, J., Pierce, W. M. & Bolli, R. Functional proteomic analysis of protein kinase Cɛ signaling complexes in the normal heart and during cardioprotection. Circ. Res. 88, 59–62 (2001).
Heinke, M. Y. et al. Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis. Electrophoresis 19, 2021–2030 (1998).
Westbrook, J. A., Yan, J. X., Wait, R., Welson, S. Y. & Dunn, M. J. Zooming-in on the proteome: very narrow-range immobilized pH gradients reveal more protein species and isoforms. Electrophoresis 22, 2865–2871 (2001).
Hoving, S. et al. Preparative two-dimensional gel electrophoresis at alkaline pH using narrow range immobilized pH gradients. Proteomics 2, 127–134 (2002).
Langen, H. et al. Two-dimensional map of the proteome of Haemophilus influenzae. Electrophoresis 21, 411–429 (2000).
Zuo, X. & Speicher, D. W. Comprehensive analysis of complex proteomes using microscale solution isoelectrofocusing prior to narrow pH range two-dimensional electrophoresis. Proteomics 2, 58–68 (2002).
Patton, W. F. Detection technologies in proteome analysis. J. Chromatogr. B 771, 3–31 (2002).
Zhou, G. et al. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell. Proteomics 1, 117–124 (2001).
Gagnon, E. et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110, 119–131 (2002).
Sabarth, N. et al. Identification of surface proteins of Helicobacter pylori by selective biotinylation, affinity purification, and two-dimensional gel electrophoresis. J. Biol. Chem. 277, 27896–27902 (2002).
Shin, B. K. et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J. Biol. Chem. DOI: 10.1074/jbc.M210455200 (2002).
Brivio, M. et al. Integrated microfluidic system enabling (bio)chemical reactions with on-line MALDI-TOF mass spectrometry. Anal. Chem. 74, 3972–3976 (2002).
Stoeckli, M., Chaurand, P., Hallahan, D. E. & Caprioli, R. M. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nature Med. 7, 493–496 (2001).
Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000).
Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869–10874 (2001).
Brenton, J. D., Aparicio, S. A. & Caldas, C. Molecular profiling of breast cancer: portraits but not physiognomy. Breast Cancer Res. 3, 77–80 (2001).
Gruvberger, S. et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61, 5979–5984 (2001).
van de Vijver, M. J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999–2009 (2002).
Chen, G. et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin. Cancer Res. 8, 2290–2305 (2002).
Opinion. Microarray standards at last. Nature 419, 323 (2002).
Pellois, J. P. et al. Individually addressable parallel peptide synthesis on microchips. Nature Biotechnol. 20, 922–926 (2002).
Knezevic, V. et al. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 1, 1271–1278 (2001).
Paweletz, C. P. et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20, 1981–1989 (2001).
Robinson, W. H. et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nature Med. 8, 295–301 (2002).
Madoz-Gurpide, J., Wang, H., Misek, D. E., Brichory, F. & Hanash, S. M. Protein based microarrays: a tool for probing the proteome of cancer cells and tissues. Proteomics 1, 1279–1287 (2001).
Zhang, L. et al. Contribution of human α-defensin 1, 2 and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298, 995–1000 (2002).
Hanash, S. Harnessing immunity for cancer marker discovery. Nature Biotechnol. 21, 37–38 (2003).
Stockert, E. et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J. Exp. Med. 187, 1349–1354 (1998).
Gourevitch, M. M. et al. Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. Br. J. Cancer 72, 934–938 (1995).
Gure, A. O. et al. Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Res. 58, 1034–1341 (1998).
Yamamoto, A., Shimizu, E., Ogura, T. & Sone, S. Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patients. Int. J. Cancer 22, 283–289 (1996).
Soussi, T. The humoral response to the tumor-suppressor gene product p53 in human cancer: implications for diagnosis and therapy. Immunol. Today 17, 354–356 (1996).
Old, L. J. & Chen, Y. T. New paths in human cancer serology. J. Exp. Med. 187, 1163–1167 (1998).
Mintz, P. J. et al. Fingerprinting the circulating repertoire cancer patients. Nature Biotechnol. 21, 57–63 (2003).
Le Naour, F. Contribution of proteomics to tumor immunology. Proteomics 1, 1295–1302 (2001).
Brichory, F. M. et al. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc. Natl Acad. Sci. USA 98, 9824–9829 (2001).
Vondriska, T. M. & Ping, P. Functional proteomics to study protection of the ischaemic myocardium. Expert Opin. Therapeut. Targets 6, 563–570 (2002).
Borodovsky, A. et al. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem. Biol. 9, 1149–1159 (2002).
Jessani, N., Liu, Y., Humphrey, M. & Cravatt, B. F. Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc. Natl Acad. Sci. USA 99, 10335–10340 (2002).
Greenbaum, D. et al. Chemical approaches for functionally probing the proteome. Mol. Cell. Proteomics 1, 60–68 (2002).
Rubenwolf, S. et al. Functional proteomics using chromophore-assisted laser inactivation. Proteomics. Proteomics 2, 241–246 (2002).
VanBogelen, R. A., Schiller, E. E., Thomas, R. D. & Neidhardt, F. C. Diagnosis of cellular states of microbial organisms using proteomics. Electrophoresis 20, 2149–2159 (1999).
Lasonder, E. et al. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 419, 537–542 (2002).
Florens, L. et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 419, 520–526 (2002).
Nilsson, C. L. Bacterial proteomics and vaccine development. Am. J. Pharmacogenomics 2, 59–65 (2002).
Eymann, C., Homuth, G., Scharf, C. & Hecker, M. Bacillus subtilis functional genomics: global characterization of the stringent response by proteome and transcriptome analysis. J. Bacteriol. 184, 2500–2520 (2002).
Haas, G. et al. Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics 2, 313–324 (2002).
Reid, S. D. et al. Postgenomic analysis of four novel antigens of group a streptococcus: growth phase-dependent gene transcription and human serologic response. J. Bacteriol. 184, 6316–6324 (2002).
Antelmann, H., Yamamoto, H., Sekiguchi, J. & Hecker, M. Stabilization of cell wall proteins in Bacillus subtilis: a proteomic approach. Proteomics 2, 591–602 (2002).
Lewis, T. S. et al. Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry. Mol. Cell 6, 1343–1354 (2000).
McKerrow, J. H. et al. A functional proteomics screen of proteases in colorectal carcinoma. Mol. Med. 6, 450–460 (2000).
Acknowledgements
I thank P. Chaurand, R. Caprioli, G. Omenn, B. Cravatt, N. Jessani, R. Kuick, L. Ilag, E. Gulari for their insightful comments, stimulating discussions and other contributions to the preparation of this review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hanash, S. Disease proteomics. Nature 422, 226–232 (2003). https://doi.org/10.1038/nature01514
Issue Date:
DOI: https://doi.org/10.1038/nature01514
This article is cited by
-
Comprehensive multi-omics analysis reveals WEE1 as a synergistic lethal target with hyperthermia through CDK1 super-activation
Nature Communications (2024)
-
Mass spectrometry-based proteomics as an emerging tool in clinical laboratories
Clinical Proteomics (2023)
-
A protein–protein interaction analysis tool for targeted cross-linking mass spectrometry
Scientific Reports (2023)
-
Molecular imaging: design mechanism and bioapplications
Science China Chemistry (2023)
-
Proteomic profiling of the rat hippocampus from the kindling models of electrical epilepsy and treatment with low-frequency deep brain stimulation: the important role of the cytoskeleton
Journal of the Iranian Chemical Society (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.